Literature DB >> 19233865

Sphingosine-1-phosphate and modulation of vascular tone.

Junsuke Igarashi1, Thomas Michel.   

Abstract

Sphingosine-1-phosphate (S1P) is a phosphorylated product of sphingosine, the core structure of the class of lipids termed sphingolipids. S1P is a naturally occurring lipid metabolite, and usually is present at a concentration of a few 100 nanomolar in human sera. S1P has been found to exert a diverse set of physiological and pathophysiological responses in mammalian tissues through the activation of heterotrimeric G-proteins that in turn modulate the activity of various downstream effecter molecules. In blood vessels, vascular endothelial cells and smooth muscle cells express specific receptors for S1P that modulate vascular tone. This article will provide a brief overview of S1P metabolism in the vasculature and will discuss some of the pathways whereby S1P regulates intracellular signal transduction pathways in endothelial and smooth muscle cells, leading to the activation of both vasorelaxation and vasoconstriction responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19233865      PMCID: PMC2674011          DOI: 10.1093/cvr/cvp064

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  84 in total

1.  Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.

Authors:  Suzanne Mandala; Richard Hajdu; James Bergstrom; Elizabeth Quackenbush; Jenny Xie; James Milligan; Rosemary Thornton; Gan-Ju Shei; Deborah Card; CarolAnn Keohane; Mark Rosenbach; Jeffrey Hale; Christopher L Lynch; Kathleen Rupprecht; William Parsons; Hugh Rosen
Journal:  Science       Date:  2002-03-28       Impact factor: 47.728

2.  Sphingosine 1-phosphate and control of vascular tone.

Authors:  Ana Paula V Dantas; Junsuke Igarashi; Thomas Michel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-06       Impact factor: 4.733

3.  Immunomodulator FTY720 Induces eNOS-dependent arterial vasodilatation via the lysophospholipid receptor S1P3.

Authors:  Markus Tölle; Bodo Levkau; Petra Keul; Volker Brinkmann; Günter Giebing; Gilbert Schönfelder; Michael Schäfers; Karin von Wnuck Lipinski; Joachim Jankowski; Vera Jankowski; Jerold Chun; Walter Zidek; Markus Van der Giet
Journal:  Circ Res       Date:  2005-03-31       Impact factor: 17.367

Review 4.  Nitric oxide insufficiency, platelet activation, and arterial thrombosis.

Authors:  J Loscalzo
Journal:  Circ Res       Date:  2001-04-27       Impact factor: 17.367

5.  Expression and regulation of endothelial nitric oxide synthase.

Authors:  K Sase; T Michel
Journal:  Trends Cardiovasc Med       Date:  1997-01       Impact factor: 6.677

Review 6.  Regulation of endothelial nitric oxide synthase: location, location, location.

Authors:  Philip W Shaul
Journal:  Annu Rev Physiol       Date:  2002       Impact factor: 19.318

7.  Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway.

Authors:  Steffen-Sebastian Bolz; Lukas Vogel; Daniel Sollinger; Roland Derwand; Cor de Wit; Gervaise Loirand; Ulrich Pohl
Journal:  Circulation       Date:  2003-06-09       Impact factor: 29.690

8.  Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets.

Authors:  Motohiro Tani; Takamitsu Sano; Makoto Ito; Yasuyuki Igarashi
Journal:  J Lipid Res       Date:  2005-08-01       Impact factor: 5.922

9.  Transactivation of vascular endothelial growth factor (VEGF) receptor Flk-1/KDR is involved in sphingosine 1-phosphate-stimulated phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS).

Authors:  Tatsuo Tanimoto; Zheng-Gen Jin; Bradford C Berk
Journal:  J Biol Chem       Date:  2002-09-10       Impact factor: 5.157

10.  Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate.

Authors:  Rajita Pappu; Susan R Schwab; Ivo Cornelissen; João P Pereira; Jean B Regard; Ying Xu; Eric Camerer; Yao-Wu Zheng; Yong Huang; Jason G Cyster; Shaun R Coughlin
Journal:  Science       Date:  2007-03-15       Impact factor: 47.728

View more
  44 in total

1.  Inhibition of Sphingosine Kinase 1 Ameliorates Angiotensin II-Induced Hypertension and Inhibits Transmembrane Calcium Entry via Store-Operated Calcium Channel.

Authors:  Parker C Wilson; Wayne R Fitzgibbon; Sara M Garrett; Ayad A Jaffa; Louis M Luttrell; Michael W Brands; Hesham M El-Shewy
Journal:  Mol Endocrinol       Date:  2015-04-14

Review 2.  Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis.

Authors:  Volker Brinkmann; Andreas Billich; Thomas Baumruker; Peter Heining; Robert Schmouder; Gordon Francis; Shreeram Aradhye; Pascale Burtin
Journal:  Nat Rev Drug Discov       Date:  2010-10-29       Impact factor: 84.694

Review 3.  Pathogenesis of Systemic Sclerosis.

Authors:  Debendra Pattanaik; Monica Brown; Bradley C Postlethwaite; Arnold E Postlethwaite
Journal:  Front Immunol       Date:  2015-06-08       Impact factor: 7.561

Review 4.  Vascular and Immunobiology of the Circulatory Sphingosine 1-Phosphate Gradient.

Authors:  Keisuke Yanagida; Timothy Hla
Journal:  Annu Rev Physiol       Date:  2016-10-21       Impact factor: 19.318

5.  Novel selective allosteric and bitopic ligands for the S1P(3) receptor.

Authors:  Euijung Jo; Barun Bhhatarai; Emanuela Repetto; Miguel Guerrero; Sean Riley; Steven J Brown; Yasushi Kohno; Edward Roberts; Stephan C Schürer; Hugh Rosen
Journal:  ACS Chem Biol       Date:  2012-09-14       Impact factor: 5.100

6.  S1P2 receptor-dependent Rho-kinase activation mediates vasoconstriction in the murine pulmonary circulation induced by sphingosine 1-phosphate.

Authors:  William S Szczepaniak; Bruce R Pitt; Bryan J McVerry
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-04-30       Impact factor: 5.464

7.  Discovery, synthesis and SAR analysis of novel selective small molecule S1P4-R agonists based on a (2Z,5Z)-5-((pyrrol-3-yl)methylene)-3-alkyl-2-(alkylimino)thiazolidin-4-one chemotype.

Authors:  Mariangela Urbano; Miguel Guerrero; Subash Velaparthi; Melissa Crisp; Peter Chase; Peter Hodder; Marie-Therese Schaeffer; Steven Brown; Hugh Rosen; Edward Roberts
Journal:  Bioorg Med Chem Lett       Date:  2011-09-20       Impact factor: 2.823

Review 8.  S1P Signaling and De Novo Biosynthesis in Blood Pressure Homeostasis.

Authors:  Anna Cantalupo; Annarita Di Lorenzo
Journal:  J Pharmacol Exp Ther       Date:  2016-06-17       Impact factor: 4.030

Review 9.  Sphingolipid De Novo Biosynthesis: A Rheostat of Cardiovascular Homeostasis.

Authors:  Linda Sasset; Yi Zhang; Teresa M Dunn; Annarita Di Lorenzo
Journal:  Trends Endocrinol Metab       Date:  2016-08-22       Impact factor: 12.015

10.  Sphingosine-1-phosphate evokes unique segment-specific vasoconstriction of the renal microvasculature.

Authors:  Zhengrong Guan; Sean T Singletary; Anthony K Cook; Janet L Hobbs; Jennifer S Pollock; Edward W Inscho
Journal:  J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.